Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical impact of genetic testing in comprehensive cardiomyopathies.

Journal of cardiology - 1 Jun 2026

Kataoka Naoya, Imamura Teruhiko, Uchida Keisuke, Kinugawa Koichiro

Abstract excerpt

BACKGROUND: Cardiomyopathies and idiopathic ventricular fibrillation have traditionally been studied as distinct entities; however, emerging evidence suggests that arrhythmias may represent an early manifestation of cardiomyopathy. The clinical utility of genetic testing in these conditions requires comprehensive evaluation. METHODS: We retrospectively analyzed 51 consecutive patients with idiopathic...

Topics

Join the communities discussing this publication.

Cardiomyopathies
Catheter Ablation
Genetic Testing
Genetic Variation
Recurrence
Ventricular Fibrillation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 41397489
DOI: 10.1016/j.jjcc.2025.12.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical impact of genetic testing in comprehensive cardiomyopathies.PMID 41397489Read ↗

Genetic testing in cardiomyopathies: updates and future perspectives.Semantic proximity Read ↗

Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.Semantic proximity Read ↗

Prevalence and Phenotypic Burden of Monogenic Arrhythmias Using Integration of Electronic Health Records With Genetics.Semantic proximity Read ↗

Impact of Cardiomyopathy and Arrhythmia Genetic Testing on Clinical Management DecisionsSemantic proximity Read ↗

Cardiac genetic test yields and genotype-phenotype correlations from large cohort investigated by medical examiner's office.Semantic proximity Read ↗

Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized MedicineSemantic proximity Read ↗

Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?Semantic proximity Read ↗

Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular GenomicsSemantic proximity Read ↗

Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study.Semantic proximity Read ↗

Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.Semantic proximity Read ↗

Approaches to Genetic Screening in Cardiomyopathies: Practical Guidance for Clinicians.Semantic proximity Read ↗

Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.